Cytotoxicity, Antimicrobial and Antioxidant Studies of the Different Plant Parts of <i>Mimosa Pudica</i>

Authors

  • Sadia Afreen Chowdhury Laboratory of Pharmacognosy and Pharmacology Department of Pharmacy Stamford University, Dhaka-1217, Bangladesh
  • Jannatul Islam Laboratory of Pharmacognosy and Pharmacology Department of Pharmacy Stamford University, Dhaka-1217, Bangladesh
  • Md Mahfujur Rahaman Laboratory of Pharmacognosy and Pharmacology Department of Pharmacy Stamford University, Dhaka-1217, Bangladesh
  • Md Mostafizur Rahman Laboratory of Pharmacognosy and Pharmacology Department of Pharmacy Stamford University, Dhaka-1217, Bangladesh
  • Nowshin Nowaz Rumzhum Laboratory of Pharmacognosy and Pharmacology Department of Pharmacy Stamford University, Dhaka-1217, Bangladesh
  • Rebeka Sultana Laboratory of Pharmacognosy and Pharmacology Department of Pharmacy Stamford University, Dhaka
  • Most. Nazma Parvin Laboratory of Pharmacognosy and Pharmacology Department of Pharmacy Stamford University, Dhaka

DOI:

https://doi.org/10.3329/sjps.v1i1.1813

Keywords:

Mimosa pudica, Mimosaceae, Cytotoxicity, Antimicrobial, DPPH, Antioxidant

Abstract

Rebeka Sultana and Most Nazma Parvin - were added as authors on 13th September 2010.

The petroleum ether, chloroform and methanol crude extracts of the two different plant parts (aerial part and root) of Mimosa pudica (Mimosaceae) were screened in vitro for cytotoxicity studies by brine shrimp lethality bioassay and antimicrobial screening by disc diffusion method. The methanol crude extract of the aerial part was screened in vitro for antioxidant activity using the 1, 1-diphenyl-2-picrylhydrazyl-hydrate (DPPH) free radical scavenging assay. The petroleum ether and methanol crude extracts of the root showed potential cytotoxic activities (LC50 0.05 μg/ml and 0.035 μg/ml respectively) whereas the other extractives showed poor cytotoxicity. All the crude extracts showed poor activity or inactivity against the test microorganisms. On the other hand, the methanol crude extract of the aerial part showed moderate antioxidant activity (IC50 296.92 μg/ml) compared to ascorbic acid (IC50 131.29 μg/ml). The overall experimental results suggest the biologically active constituents present in the methanolic extract of Mimosa pudica and justify its use in folkloric remedies.

Key Words: Mimosa pudica, Mimosaceae, Cytotoxicity, Antimicrobial, DPPH, Antioxidant. 

doi:10.3329/sjps.v1i1.1813

S. J. Pharm. Sci. 1(1&2): 80-84

Downloads

Download data is not yet available.

Downloads

How to Cite

Chowdhury, S. A., Islam, J., Rahaman, M. M., Rahman, M. M., Rumzhum, N. N., Sultana, R., & Parvin, M. N. (2009). Cytotoxicity, Antimicrobial and Antioxidant Studies of the Different Plant Parts of <i>Mimosa Pudica</i>. Stamford Journal of Pharmaceutical Sciences, 1(1), 80–84. https://doi.org/10.3329/sjps.v1i1.1813

Issue

Vol. 1 No. 1 (2008)

Section

Short Communications

License

As a condition of publication, all authors must transfer copyright to the Department of Pharmacy. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission, and that the final version of the manuscript has been seen and approved by them.

Each author must agree to this statement

Authorship: This manuscript is the original work of the authors, each of whom has read and approved of the work. Each author satisfied the requirements contained in 'Author Guidelines' having participated sufficiently in the work to take public responsibility for the content. This participation includes:

  • Conception or design of the study, or analysis and interpretation of data, or both
  • Drafting the article or revising it for critically important intellectual content
  • Approval of the final 'to be published' version

All authors must take responsibility for the integrity of the work. Participating solely in the collection of data does not justify authorship.

Prior publication: This work is not currently under consideration by any other journal. Information about prior publication of any part of this work, or inclusion of patients detailed herein in any other work, has been provided in the cover letter.

Conflict of interest: Details of any financial or other relationship between any author and any other party that may lead to a conflict of interest with the subject or any materials mentioned in this article have been disclosed in the cover letter.